Descriptive epidemiology of ependymal tumours in the United States

British Journal of Cancer

Volumn 108, Issue 11, 2013, Pages 2367-2371

  Villano, J L ^a   Parker, C K ^b   Dolecek, T A ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Brain tumour; Ependymoma; Epidemiology; Incidence; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; EPENDYMOMA; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; REGISTER; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPENDYMOMA; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; REGISTRIES; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84884170480     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.221     Document Type: Article

References (25)

1. Amirian ES, Armstrong TS, Gilbert MR, Scheurer ME (2012) Predictors of survival among older adults with ependymoma. J Neurooncol 107: 183–189.
2. Bishop AJ, McDonald MW, Chang AL, Esiashvili N (2012) Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results (SEER) Data. Int J Radiat Oncol Biol Phys 82: 341–347.
3. Brody SL, Yan XH, Wuerffel MK, Song SK, Shapiro SD (2000) Ciliogenesis and left-right axis defects in forkhead factor HFH-4-null mice. Am J Respir Cell Mol Biol 23: 45–51.
4. Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, Weber DC, Ricardi U, Slowinski J, Brandes A (2012) Epidemiology of glial and nonglial brain tumours in Europe. Eur J Cancer 48: 1532–1542.
5. Del Bigio MR (1995) The ependyma: a protective barrier between brain and cerebrospinal fluid. Glia 14: 1–13.
6. Dolecek TA, Propp JM, Stroup N, Kruchko C (2012) CBTRUS Statistical Report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neurooncol 14(suppl 5): v1–v49.
7. Fritz AG. World Health Organization (2000) International Classification of Diseases for Oncology: ICD-O. 3rd edn World Health Organization: Geneva, Switzerland.
8. Guyotat J, Signorelli F, Desme S, Frappaz D, Madarassy G, Montange MF, Jouvet A, Bret P (2002) Intracranial ependymomas in adult patients: analyses of prognostic factors. J Neurooncol 60: 255–268.
9. Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schottler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S (2010) Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28: 3182–3190.
10. Koshy M, Rich S, Merchant TE, Mahmood U, Regine WF, Kwok Y (2011) Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma. J Neurooncol 105: 583–590.
11. Louis DN. International Agency for Research on Cancer & World Health Organization (2007) WHO Classification of Tumours of the Central Nervous System. 4th edn. International Agency for Research on Cancer: Lyon, France.
12. Marks JE, Adler SJ (1982) A comparative study of ependymomas by site of origin. Int J Radiat Oncol Biol Phys 8: 37–43.
13. McCarthy BJ, Propp JM, Davis FG, Burger PC (2008) Time trends in oligodendroglial and astrocytic tumor incidence. Neuroepidemiology 30: 34–44.
14. McGuire CS, Sainani KL, Fisher PG (2009a) Both location and age predict survival in ependymoma: a SEER study. Pediatr Blood Cancer 52: 65–69.
15. McGuire CS, Sainani KL, Fisher PG (2009b) Incidence patterns for ependymoma: a Surveillance, Epidemiology, and End Results study. J Neurosurg 110: 725–729.
16. Mork SJ, Loken AC (1977) Ependymoma: a follow-up study of 101 cases. Cancer 40: 907–915.
17. Rodriguez D, Cheung MC, Housri N, Quinones-Hinojosa A, Camphausen K, Koniaris LG (2009) Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973–2005). J Surg Res 156: 340–351.
18. Scheithauer BW (1978) Symptomatic subependymoma. Report of 21 cases with review of the literature. J Neurosurg 49: 689–696.
19. SEER (2011a) http://seer.cancer.gov, SEER*Stat Database: Incidence—SEER 13 Regs Research Data, Nov 2010 Sub (1992–2008) (Katrina/Rita Population Adjustment)—Linked to County Attributes—Total U.S., 1969– 2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011 (updated 28 October 2011), based on the November 2010 submission.
20. SEER (2011b) Surveillance Research Program SEER*Stat 8.0.2 software. National Cancer Institute; www.seer.cancer.gov/seerstat.
21. Sonneland PR, Scheithauer BW, Onofrio BM (1985) Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer 56: 883–893.
22. Spassky N, Merkle FT, Flames N, Tramontin AD, Garcia-Verdugo JM, Alvarez-Buylla A (2005) Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis. J Neurosci 25: 10–18.
23. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T, Gilbertson RJ (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8: 323–335.
24. Thuppal S, Propp J M, McCarthy B J (2006) Average years of potential life lost in those who have died from brain and CNS tumors in the USA. Neuroepidemiology 27: 22–27.
25. Wani K, Armstrong TS, Vera-Bolanos E (2012) A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol 123: 727–738.